| CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer | |
| Wei, Yichou; Lin, Chao; Li, He; Xu, Zhiying; Wang, Jieti; Li, Ruochen; Liu, Hao; Zhang, Heng; He, Hongyong; Xu, Jiejie | |
| 刊名 | CANCER IMMUNOLOGY IMMUNOTHERAPY
 |
| 2018 | |
| 卷号 | 67期号:2 |
| 关键词 | Gastric cancer CXCL13 Prognosis Biomarker Postoperative adjuvant chemotherapy |
| ISSN号 | 0340-7004 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3607417 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wei, Yichou,Lin, Chao,Li, He,et al. CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY,2018,67(2). |
| APA | Wei, Yichou.,Lin, Chao.,Li, He.,Xu, Zhiying.,Wang, Jieti.,...&Xu, Jiejie.(2018).CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.CANCER IMMUNOLOGY IMMUNOTHERAPY,67(2). |
| MLA | Wei, Yichou,et al."CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer".CANCER IMMUNOLOGY IMMUNOTHERAPY 67.2(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论